Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ERICH M STURGIS and KRISTINA R DAHLSTROM.
ERICH M STURGIS
Connection Strength
10.136
KRISTINA R DAHLSTROM
  1. Prevention and Screening of HPV Malignancies. Semin Radiat Oncol. 2021 10; 31(4):297-308.
    View in: PubMed
    Score: 0.800
  2. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial. Oral Oncol. 2021 09; 120:105397.
    View in: PubMed
    Score: 0.786
  3. Diagnostic accuracy of serum antibodies to human papillomavirus type 16 early antigens in the detection of human papillomavirus-related oropharyngeal cancer. Cancer. 2017 Dec 15; 123(24):4886-4894.
    View in: PubMed
    Score: 0.604
  4. Human Papillomavirus-Associated Oropharyngeal Cancer: Not Just White Men Anymore. JAMA Oncol. 2017 Feb 01; 3(2):161-162.
    View in: PubMed
    Score: 0.579
  5. Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories. J Clin Oncol. 2016 06 01; 34(16):1848-54.
    View in: PubMed
    Score: 0.542
  6. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior. Oral Oncol. 2015 Sep; 51(9):832-8.
    View in: PubMed
    Score: 0.518
  7. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer. Cancer. 2015 Oct 01; 121(19):3455-64.
    View in: PubMed
    Score: 0.518
  8. HPV Serum Antibodies as Predictors of Survival and Disease Progression in Patients with HPV-Positive Squamous Cell Carcinoma of the Oropharynx. Clin Cancer Res. 2015 Jun 15; 21(12):2861-9.
    View in: PubMed
    Score: 0.517
  9. An evolution in demographics, treatment, and outcomes of oropharyngeal cancer at a major cancer center: a staging system in need of repair. Cancer. 2013 Jan 01; 119(1):81-9.
    View in: PubMed
    Score: 0.421
  10. Differences in history of sexual behavior between patients with oropharyngeal squamous cell carcinoma and patients with squamous cell carcinoma at other head and neck sites. Head Neck. 2011 Jun; 33(6):847-55.
    View in: PubMed
    Score: 0.371
  11. HPV vaccination. Inaccurate assumptions about oropharyngeal cancer. BMJ. 2009 Nov 02; 339:b4525.
    View in: PubMed
    Score: 0.351
  12. Squamous cell carcinoma of the head and neck in never smoker-never drinkers: a descriptive epidemiologic study. Head Neck. 2008 Jan; 30(1):75-84.
    View in: PubMed
    Score: 0.309
  13. Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res. 2003 Jul; 9(7):2620-6.
    View in: PubMed
    Score: 0.226
  14. Characterization of the oral microbiota among middle-aged men with and without human papillomavirus infection. Oral Oncol. 2023 07; 142:106401.
    View in: PubMed
    Score: 0.224
  15. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic. Expert Rev Anticancer Ther. 2022 07; 22(7):751-761.
    View in: PubMed
    Score: 0.210
  16. Conditional survival among patients with oropharyngeal cancer treated with radiation therapy and alive without recurrence 5 years after diagnosis. Cancer. 2021 04 15; 127(8):1228-1237.
    View in: PubMed
    Score: 0.189
  17. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review. JAMA Otolaryngol Head Neck Surg. 2020 07 01; 146(7):656-664.
    View in: PubMed
    Score: 0.183
  18. Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma. Head Neck. 2020 09; 42(9):2440-2452.
    View in: PubMed
    Score: 0.182
  19. Projected oropharyngeal carcinoma incidence among middle-aged US men. Head Neck. 2019 09; 41(9):3226-3234.
    View in: PubMed
    Score: 0.170
  20. Reply to "Letter to the Editor in response to the article, 'The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis'". Oral Oncol. 2018 11; 86:307.
    View in: PubMed
    Score: 0.163
  21. The epidemiology of oral human papillomavirus infection in healthy populations: A systematic review and meta-analysis. Oral Oncol. 2018 07; 82:91-99.
    View in: PubMed
    Score: 0.158
  22. Medical Care Cost of Oropharyngeal Cancer among Texas Patients. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1443-1449.
    View in: PubMed
    Score: 0.151
  23. Squamous cell carcinoma of the oral cavity often overexpresses p16 but is rarely driven by human papillomavirus. Oral Oncol. 2016 May; 56:47-53.
    View in: PubMed
    Score: 0.136
  24. HPV16 antibodies as risk factors for oropharyngeal cancer and their association with tumor HPV and smoking status. Oral Oncol. 2015 Jul; 51(7):662-7.
    View in: PubMed
    Score: 0.128
  25. Epidemiology of HPV-associated oropharyngeal cancer. Oral Oncol. 2014 May; 50(5):380-6.
    View in: PubMed
    Score: 0.117
  26. Clinical management of squamous cell carcinoma of the oropharynx: how does this differ for HPV-related tumors? Future Oncol. 2013 Oct; 9(10):1413-6.
    View in: PubMed
    Score: 0.113
  27. Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers. Cancer. 2013 Jul 15; 119(14):2593-601.
    View in: PubMed
    Score: 0.111
  28. Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2013 Jun; 35(6):794-9.
    View in: PubMed
    Score: 0.105
  29. Serum cotinine concentration and wound complications in head and neck reconstruction. Plast Reconstr Surg. 2008 Feb; 121(2):451-457.
    View in: PubMed
    Score: 0.078
  30. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys. 2005 Jul 01; 62(3):665-71.
    View in: PubMed
    Score: 0.065
  31. A pilot study of Helicobacter pylori infection and risk of laryngopharyngeal cancer. Head Neck. 2005 Jan; 27(1):22-7.
    View in: PubMed
    Score: 0.063
  32. Gamma radiation-induced apoptosis, G2 delay, and the risk of salivary and thyroid carcinomas--a preliminary report. Head Neck. 2004 Jul; 26(7):612-8.
    View in: PubMed
    Score: 0.061
  33. Stepped Behavioral and Biological Screening for Oral Oncogenic HPV DNA in Middle-aged and Elderly Adults: A Feasibility Study. Cancer Prev Res (Phila). 2023 03 01; 16(3):127-132.
    View in: PubMed
    Score: 0.055
  34. A Cross-Sectional Study of the Prevalence of Anal Dysplasia among Women with High-Grade Cervical, Vaginal, and Vulvar Dysplasia or Cancer: The PANDA Study. Cancer Epidemiol Biomarkers Prev. 2022 12 05; 31(12):2185-2191.
    View in: PubMed
    Score: 0.054
  35. DNA repair gene ERCC1 and ERCC2/XPD polymorphisms and risk of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg. 2002 Sep; 128(9):1084-8.
    View in: PubMed
    Score: 0.053
  36. Genetic variants in CYP2B6 and HSD17B12 associated with risk of squamous cell carcinoma of the head and neck. Int J Cancer. 2022 08 15; 151(4):553-564.
    View in: PubMed
    Score: 0.052
  37. Detection accuracy of the Cobas HPV assay for high-risk HPV in head and neck FNA biopsy specimens. Cancer Cytopathol. 2022 07; 130(7):523-530.
    View in: PubMed
    Score: 0.051
  38. Association of pretreatment body mass index with risk of head and neck cancer: a large single-center study. Am J Cancer Res. 2021; 11(5):2343-2350.
    View in: PubMed
    Score: 0.049
  39. An economic and disease transmission model of human papillomavirus and oropharyngeal cancer in Texas. Sci Rep. 2021 01 19; 11(1):1802.
    View in: PubMed
    Score: 0.048
  40. Blood-based biomarkers of human papillomavirus-associated cancers: A systematic review and meta-analysis. Cancer. 2021 03 15; 127(6):850-864.
    View in: PubMed
    Score: 0.047
  41. Lifetime health care costs of oropharyngeal cancer for commercially insured patients in the United States. Head Neck. 2020 09; 42(9):2321-2329.
    View in: PubMed
    Score: 0.045
  42. A Genome-Wide Association Study Identifies Two Novel Susceptible Regions for Squamous Cell Carcinoma of the Head and Neck. Cancer Res. 2020 06 15; 80(12):2451-2460.
    View in: PubMed
    Score: 0.045
  43. Direct medical cost of oropharyngeal cancer among patients insured by Medicaid in Texas. Oral Oncol. 2019 09; 96:21-26.
    View in: PubMed
    Score: 0.043
  44. Cost of treating recurrent respiratory papillomavirus in commercially insured and medicaid patients. Laryngoscope. 2020 05; 130(5):1186-1194.
    View in: PubMed
    Score: 0.043
  45. Prevalence of high-grade anal dysplasia among women with high-grade lower genital tract dysplasia or cancer: Results of a pilot study. Gynecol Oncol. 2019 05; 153(2):266-270.
    View in: PubMed
    Score: 0.042
  46. Age-Structured Population Modeling of HPV-related Cervical Cancer in Texas and US. Sci Rep. 2018 09 25; 8(1):14346.
    View in: PubMed
    Score: 0.041
  47. A TGF-?1 genetic variant at the miRNA187 binding site significantly modifies risk of HPV16-associated oropharyngeal cancer. Int J Cancer. 2018 09 15; 143(6):1327-1334.
    View in: PubMed
    Score: 0.039
  48. Apoptotic capacity and risk of squamous cell carcinoma of the head and neck. Eur J Cancer. 2017 02; 72:166-176.
    View in: PubMed
    Score: 0.036
  49. Human papillomavirus integration pattern and demographic, clinical, and survival characteristics of patients with oropharyngeal squamous cell carcinoma. Head Neck. 2016 08; 38(8):1139-44.
    View in: PubMed
    Score: 0.034
  50. Reduced DNA double-strand break repair capacity and risk of squamous cell carcinoma of the head and neck--A case-control study. DNA Repair (Amst). 2016 Apr; 40:18-26.
    View in: PubMed
    Score: 0.034
  51. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016 04; 17(4):440-451.
    View in: PubMed
    Score: 0.034
  52. A variant at a potentially functional microRNA-binding site in BRIP1 was associated with risk of squamous cell carcinoma of the head and neck. Tumour Biol. 2016 Jun; 37(6):8057-66.
    View in: PubMed
    Score: 0.034
  53. Telomere length in peripheral blood lymphocytes contributes to the development of HPV-associated oropharyngeal carcinoma. Cancer Res. 2013 Oct 01; 73(19):5996-6003.
    View in: PubMed
    Score: 0.028
  54. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res. 2010 Sep 15; 70(18):7199-208.
    View in: PubMed
    Score: 0.023
  55. Association of TGF-beta1 genetic variants with HPV16-positive oropharyngeal cancer. Clin Cancer Res. 2010 Mar 01; 16(5):1416-22.
    View in: PubMed
    Score: 0.022
  56. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis. 2008 Apr; 29(4):875-9.
    View in: PubMed
    Score: 0.019
  57. A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer. 2002 Jun 20; 99(6):869-72.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.